There are 807 resources available
Discussion led by the Chair
Presenter: Sung-Bae Kim
Session: Immunotherapy for early TNBC: Who, how, and for how long?
Resources:
Slides
Webcast
Discussion led by the Chair
Presenter: James Chih-Hsin Yang
Session: It takes two to tango: Targeting fusion proteins
Resources:
Slides
Webcast
Discussion led by the Chair
Presenter: Jinsoo Chung
Session: How to treat non-clear cell RCC
Resources:
Slides
Webcast
Mentors
Presenter: Lisa Licitra
Session: Meet your mentor 1
Resources:
Slides
Welcome and introduction
Presenter: Elaine Lim
Session: Roche - Transforming the journey for HER2+ breast cancer patients
Resources:
Webcast
Welcome and opening
Presenter: Hwai Loong Kong
Session: Ipsen - Exploring optimal management and treatment sequencing in NSCLC, HCC and RCC
Resources:
Webcast
Transforming the experience of patients with HER2+ BC with recent clinical trials of PH FDC SC
Presenter: Shu Wang
Session: Roche - Transforming the journey for HER2+ breast cancer patients
Resources:
Webcast
Current management of NSCLC in Asia Pacific
Presenter: Thanyanan Baisamut (Reungwetwattana)
Session: Ipsen - Exploring optimal management and treatment sequencing in NSCLC, HCC and RCC
Resources:
Webcast
Value of subcutaneous treatment options for the healthcare system: Introducing flexible care an opportunity to bring treatment closer to patients
Presenter: Christian Jackisch
Session: Roche - Transforming the journey for HER2+ breast cancer patients
Resources:
Webcast
What’s new in the management of non-mutated NSCLC after progression to immunotherapy treatment
Presenter: Solange Peters
Session: Ipsen - Exploring optimal management and treatment sequencing in NSCLC, HCC and RCC
Resources:
Webcast